CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12 | -20.0% | 416 | -10.7% | 0.00% | – |
| Q2 2023 | $15 | -11.8% | 466 | -1.7% | 0.00% | – |
| Q1 2023 | $17 | -19.0% | 474 | +5.3% | 0.00% | – |
| Q4 2022 | $21 | -99.9% | 450 | -16.4% | 0.00% | – |
| Q3 2022 | $26,000 | +116.7% | 538 | +83.6% | 0.00% | – |
| Q2 2022 | $12,000 | 0.0% | 293 | -11.7% | 0.00% | – |
| Q1 2022 | $12,000 | -20.0% | 332 | +1.2% | 0.00% | – |
| Q4 2021 | $15,000 | – | 328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |